All News
ACIP Recommendations for Pfizer Vaccine Candidate
The CDC advisory panel, ACIP, has voted and declared that the first wave of vaccines should go to the front line healthcare workers and elderly residents in long term care facilities as part of Phase1a. The decision was not unanimous.
Read Article
Revisit #ACR20 through our podcast!
Best Practices for APL Testing,
Is COVID19 infection bad for rheumatic disease patients?
Pregnancy in SpA Patients
A New Pathway (Deucravacitinib) in Psoriatic Arthritis
https://t.co/kmoOL4d3oF https://t.co/qQQd1aJm8K
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @bella_mehta : Check out our work #racialdisparities in bilateral knee replacement -10 yr USA national study - ⬇️utilization in AA but NOT ⬆️complications. #ACR20 @RheumNow ABS#1633 https://t.co/zje7ntxpzA https://t.co/Cix9G10duj
Links:
Dr. John Cush RheumNow ( View Tweet)
Hesitancy around Steroids and Vaccines: Dr. Kevin Winthrop discusses two issues -- steroids and vaccines -- by looking at Abstracts 1014, 0632, 0634 and 1135 at #ACR20.
https://t.co/XCNujARvcU https://t.co/Sxr7H4WtZ2
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @doctorRBC : Abs#1539 Used US to dx GCA by Halo Count and Halo Score in pts with elevated inflammatory markers. Would you use US to dx GCA? @RheumNow #ACR20
Dr. John Cush RheumNow ( View Tweet)
Roundtable on Gout: What's Hot at #ACR20 with Gout Faculty
https://t.co/bCFQJuagsP https://t.co/ws0yVkygYH
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @RichardPAConway : Dr Baker reports on non-invasive vagal nerve stimulation to treat RA. 30 patients over 12 weeks. Mean DAS28-CRP decreased by 1.4. 53% achieved ACR20, 33% ACR50, 17% ACR70 @rheumnow #ACR20 Abstr#1995 #ACRbest https://t.co/qMOinHd3oY
Dr. John Cush RheumNow ( View Tweet)
Zoster Vaccine in Rheumatic Disease: Dr. David Liew ( @drdavidliew) #ACR20
https://t.co/5YrNUVMNB2 https://t.co/X6F4CeJzCH
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @doctorRBC : AxSpa pts had Significant Gut Microbiome Differences in:
1⃣Disease activity and duration
2⃣Enthesitis
3⃣Radiographic involvement
Abs#1853 https://t.co/ynemrgsP3W
Dr. John Cush RheumNow ( View Tweet)
Anakinra in Pediatric, Adult Still's Disease: Dr. Bella Mehta ( @bella_mehta) #ACR20
https://t.co/QiBEI11LY5 https://t.co/GTf7iUsfGt
Links:
Dr. John Cush RheumNow ( View Tweet)
Tight Control Tune: Third Verse, Same as the First? TICOSPA. Dr. Jeff Curtis ( @RADoctor) reviews abstract #1444 at #ACR20.
https://t.co/4tqWuzwn54 https://t.co/u0vn4d1yF8
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @drdavidliew :The 'triple M' irAEs (myositis/myocarditis/MG): one of the rheumatic irAEs where autoAb are freq pos
Nice systematic review:
any autoAb+ 61% tested
MG+ 59% tested
MSA+ in 27% tested (18/67, 11 had myositis alone) https://t.co/aQHapPbjw9
Dr. John Cush RheumNow ( View Tweet)
Check out our latest.
PIANO Study - Safety of Biologics in Pregnancy
https://t.co/XskLByJZ9n https://t.co/JBHKo0T0jX
Links:
Dr. John Cush RheumNow ( View Tweet)
New podcast!
Dr Jack Cush takes questions from RheumNow listeners
PIANO Study - Safety of Biologics in Pregnancy
Premature osteoporosis and high tryptase
Mega-methotrexate doses
SLE criteria and SLEDAI substitutions
https://t.co/45n3KjJHqs
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @uptoTate : Study out of China, #ABS1892 shows that patient reported outcomes using self assessments are important in AS T2T and decreasing flare rates #ACR20 @RheumNow. https://t.co/vWjvAEeDMi https://t.co/HdMKSkkJ8I
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @RichardPAConway : Dr Kaellmark reports on immunogenicity of adjuvant herpes zoster subunit vaccine in RA patients treated with JAKi. 40 RA patients and 20 controls. Satisfactory serological responses and tolerability seen. @rheumnow #ACR20 Abstr#1997 https://t.co/TR9IS9hUgu
Dr. John Cush RheumNow ( View Tweet)
Missing the Mark: AxSpa Treat to Target (TICOSPA Trial): Dr. Lianne Gensler #ACR20
https://t.co/ePrhQ90kwD
Links:
Dr. John Cush RheumNow ( View Tweet)
Check out our latest article from Richard Conway ( @RichardPAConway) #ACR20
The tantalising prospect of glucocorticoid-free treatments for systemic vasculitis
https://t.co/VG1ah3Nq5c https://t.co/js3l527VHg
Links:
Dr. John Cush RheumNow ( View Tweet)
Revisit #ACR20 through the RheumNow podcast. Day 2, Part III available now.
https://t.co/rgvlZzVMkX
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @MeralElRamahiMD : A large observat study showed no difference in risk of major CV events in RA pts that were newly started on either MTX or HCQ. A greater stroke risk but lower risk of MI; hospitalized HF was seen in MTX initiators. #Abst1993 #ACR20
Dr. John Cush RheumNow ( View Tweet)